Convulsant doses of abused synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA and JWH-018 do not elicit electroencephalographic (EEG) seizures in male mice
- 6 August 2022
- journal article
- research article
- Published by Springer Science and Business Media LLC in Psychopharmacology
- Vol. 239 (10), 3237-3248
- https://doi.org/10.1007/s00213-022-06205-6
Abstract
Rationale Synthetic cannabinoid receptor agonists (SCRAs) are found in illicit smoking products, such as “K2” or “Spice.” Convulsions are commonly reported adverse effects of SCRAs but are poorly understood. Objectives We determined convulsant effects of SCRAs AB-PINACA, and 5F-ADB-PINACA in adult male NIH Swiss mice, and then determined if convulsant effects of AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, and JWH-018 elicited seizure-like effects using EEG. Methods Mice were administered SCRAs or pentylenetetrazole (PTZ) and placed in observation chambers where convulsant effects were scored. The capacity of the CB1R antagonist rimonabant, the benzodiazepine diazepam, or the non-specific CYP450 inhibitor 1-aminobenzotriazole (1-ABT) to attenuate convulsant effects was determined. Other mice were prepared with EEG headmounts to ascertain whether observed convulsions occurred concurrently with seizure-like effects by assessing root-mean-square (RMS) power, high amplitude EEG spike analysis, and videography. Results Mice receiving AB-PINACA or 5F-ADB-PINACA exhibited dose-dependent convulsant effects that were blocked by 10 mg/kg rimonabant pretreatment but not by pretreatment with 10 mg/kg diazepam; these convulsant effects were not altered in the presence of 100 mg/kg 1-ABT. Repeated administration of 10 mg/kg AB-PINACA and 3 mg/kg 5F-ADB-PINACA produced partial tolerance to convulsant effects but did not lead to cross-tolerance to PTZ-induced convulsions. In EEG studies, convulsant doses of AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, and JWH-018 did not produce seizures concomitantly with convulsions. Conclusions These data extend previous findings of convulsant effects of SCRAs and suggest that convulsant effects of AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, and JWH-018 are CB1R-mediated but are not associated with electroencephalographic seizures. These results further suggest that benzodiazepines may not effectively treat convulsions elicited by SCRA use in humans.Funding Information
- National Institute on Drug Abuse (DA039143)
- U.S. Department of Justice
This publication has 78 references indexed in Scilit:
- Cannabidivarin is anticonvulsant in mouse and ratBritish Journal of Pharmacology, 2012
- Cannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic CardiomyopathyDiabetes, 2012
- JWH-018 and JWH-073: Δ9-Tetrahydrocannabinol-Like Discriminative Stimulus Effects in MonkeysThe Journal of pharmacology and experimental therapeutics, 2011
- Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and ActivityPLOS ONE, 2011
- Neuropsychiatric adverse effects signal the end of the line for rimonabantNature Reviews Cardiology, 2010
- Children are key to CVD preventionNature Reviews Cardiology, 2010
- Evaluation of EMG processing techniques using Information TheoryBioMedical Engineering OnLine, 2010
- Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In VivoThe Journal of pharmacology and experimental therapeutics, 2009
- One-Way Cross-Sensitization and Cross-Tolerance to Seizure Activity from Cocaine to LidocaineAnnals of the New York Academy of Sciences, 1996
- Chronic Ethanol Treatment Alters Brain Levels of γ‐Aminobutyric AcidA Receptor Subunit mRNAs: Relationship to Genetic Differences in Ethanol Withdrawal Seizure SeverityJournal of Neurochemistry, 1991